Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Li‑Xu Yan
Prognostic Value of Delta‑like Protein 3 Combined With Thyroid Transcription Factor‑1 in Small‑cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Related publications
Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Activation of Insulin-Like Growth Factor 1 Receptor in Patients With Non-Small Cell Lung Cancer
Oncotarget
Oncology
Prognostic Value of KRAS/TP53/PIK3CA in Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Prognostic Roles of Mitochondrial Transcription Termination Factors in Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Prognostic Value of FDG-PET Scans at Diagnosis in Small Cell Lung Cancer
Journal of Biomedical Graphics and Computing
Predictive and Prognostic Value of 18f-Fluorodeoxyglucose Uptake Combined With Thymidylate Synthase Expression in Patients With Advanced Non-Small Cell Lung Cancer
Scientific Reports
Multidisciplinary
Prognostic Value of Red Blood Cell Distribution Width in Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death-1 Antibody
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
OA05.03 Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
